Skip to content
Axcess News – Lifestyle
Author:
Knoa Pharma
Knoa Pharma and GCAR Announce First Newly Diagnosed Glioblastoma Patient Randomized in Phase 2/3 GBM AGILE Evaluation of Tinostamustine and First Recurrent Patient Dosed
June 24, 2026
Knoa Pharma to Present Pipeline Assets at BIO International Convention 2026
June 22, 2026